Medical Plastics Market Report by Material (Polyvinyl Chloride, Polypropylene, Engineering Plastics, Polyethylene, Polystyrene, Silicones, and Others), Application, and Region 2025-2033
상품코드:1819978
리서치사:IMARC
발행일:2025년 09월
페이지 정보:영문 146 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계 의료용 플라스틱 시장 규모는 2024년 293억 달러에 달했습니다. 향후 IMARC Group은 2033년에는 477억 달러에 달하고, 2025-2033년 연평균 성장률(CAGR)은 5.57%를 보일 것으로 예측했습니다. 의료기기 및 장비에 대한 수요 증가, 만성 질환의 확산, 엄격한 규제 기준, 노인 인구 증가, 감염 예방에 중점을 둔 코로나19 유행, 기술 발전, 최소침습수술(MIS) 등이 시장 전망을 밝게 만드는 요인 중 일부입니다.
의료용 플라스틱 시장 동향 :
의료기기에 대한 수요 증가
세계적으로 의료기기에 대한 수요가 증가하고 있는 것이 의료용 플라스틱 시장의 성장 요인으로 작용하고 있습니다. 의료시설이 환자 수요 증가에 대응하기 위해 노력하는 가운데, 플라스틱 의료기기는 다재다능하고 비교적 저렴한 가격, 의료제품의 엄격한 규제 사양을 충족하는 플라스틱 의료기기에 대한 수요가 증가하고 있습니다. 진단 기기에서 수술 도구에 이르기까지 의료용 플라스틱은 다양한 용도에 적합한 다재다능함을 가지고 있습니다.
만성질환 급증
당뇨병, 심혈관 질환에서 호흡기 질환에 이르기까지 만성질환이 급증하고 있는 것도 이러한 추세의 큰 요인입니다. 이러한 질병의 유병률이 증가함에 따라 전 세계적으로 의료 개입 및 치료에 대한 수요가 증가하고 있습니다. 그 결과, 플라스틱으로 만든 다양한 의료기기, 도구 및 제품이 이러한 수요 증가에 대응하기 위해 필요하게 되었으며, 내구성, 유연성, 생체 적합성 및 질병 관리 및 통제에 있어 다양한 용도에 적합하기 때문에 의료용 플라스틱에 대한 수요가 더욱 급증하고 있습니다. 수요는 더욱 급증하고 있습니다.
엄격한 규제 기준
의료용 플라스틱에 대한 수요는 의료기기 및 제품의 안전성과 유효성에 대한 엄격한 규제 기준에 의해 주도되고 있습니다. 전 세계 규제 기관은 의료용으로 사용되는 재료가 고품질이며 환자의 건강에 안전하다는 것을 보장하기 위해 가이드라인을 제공합니다. 의료용 플라스틱은 생체 적합성, 무균성, 내화학성 등 규제 요건에 부합하는 특징적인 특성을 가지고 있습니다. 그 결과, 의료시설에서는 환자 안전과 감염 예방이 그 어느 때보다 우선시되고 있으며, 많은 의료 장비와 기구는 이러한 우선순위를 지원하는 고품질 플라스틱을 선호하고 있습니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
조사 목적
이해관계자
데이터 소스
1차 정보
2차 정보
시장 추정
보텀업 접근
톱다운 접근
조사 방법
제3장 주요 요약
제4장 서론
제5장 세계의 의료용 플라스틱 시장
시장 개요
시장 실적
COVID-19의 영향
시장 예측
제6장 시장 분석 : 재료별
폴리염화비닐(PVC)
폴리프로필렌(PP)
엔지니어링 플라스틱
폴리에틸렌(PE)
폴리스티렌(PS)
실리콘
기타
제7장 시장 분석 : 용도별
일회용
약물전달 기기
진단 기기
카테터
수술 기구
기타
제8장 시장 분석 : 지역별
북미
미국
캐나다
아시아태평양
중국
일본
인도
한국
호주
인도네시아
기타
유럽
독일
프랑스
영국
이탈리아
스페인
러시아
기타
라틴아메리카
브라질
멕시코
기타
중동 및 아프리카
제9장 SWOT 분석
제10장 밸류체인 분석
제11장 Porter의 Five Forces 분석
제12장 가격 분석
제13장 경쟁 구도
시장 구조
주요 기업
주요 기업 개요
Arkema SA
BASF SE
Celanese Corporation
Covestro AG
The Dow Chemical Company
DuPont de Nemours Inc
Evonik Industries AG
Exxon Mobil Corporation
SABIC
Solvay S.A.
The Lubrizol Corporation(Berkshire Hathaway Inc.)
Trinseo PLC
LSH
영문 목차
영문목차
The global medical plastics market size reached USD 29.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 47.7 Billion by 2033, exhibiting a growth rate (CAGR) of 5.57% during 2025-2033. Increasing demand for medical devices and equipment, growing prevalence of chronic diseases, stringent regulatory standards, rising geriatric population, COVID-19 pandemic emphasizing infection prevention, technological advancements, and minimally invasive surgical (MIS) procedures are some of the factors creating a positive outlook for the market.
Medical Plastics Market Trends:
Escalating demand for medical devices
The increasing requirement for medical devices and equipment across the world is a key growth factor for the global medical plastics market.. As health facilities seek to meet the rising patient demand, the demand for plastics-made medical devices grows since they are versatile and relatively affordable and meet stringent regulatory specifications for medical products. From diagnostic equipment to surgical instruments, medical-grade plastics are versatile enough to fit into a variety of applications.
Surging prevalence of chronic diseases
Another major factor contributing to the trend is the rapid rise in chronic conditions, ranging from diabetes and cardiovascular conditions to respiratory disorders. Due to the increasing prevalence of such diseases, medical interventions and therapy are in high demand globally. As a result, various medical equipment, tools, and products made of plastics are needed to support this growing need, which has further surged the demand for medical plastics as they are durable, flexible, and biocompatible, making them perfect for multiple applications in disease control and management.
Stringent regulatory standards
The demand for medical plastics is also driven by the strict regulatory standards on medical devices and products safety and efficacy. Regulatory bodies across the globe provide guidelines for materials used in healthcare applications to ensure that they are of high quality and safe for patient health. Medical grade plastics have properties such as biocompatibility, sterility, and chemical resistance, characteristic of the regulatory requirements. Consequently, as patient safety and infection control receives unprecedented prioritization by healthcare facilities, many prefer medical equipment and devices made of quality plastics that support these priorities.
Medical Plastics Market Segmentation:
Breakup by Material:
Polyvinyl Chloride (PVC)
Polypropylene (PP)
Engineering Plastics
Polyethylene (PE)
Polystyrene (PS)
Silicones
Others
Polyvinyl chloride (PVC) represents the leading market segment
The polyvinyl chloride (PVC) segment in medical plastics is driven by several key factors, such as the increasing demand for cost-effective and versatile materials in medical device manufacturing propels the growth of PVC usage. PVC offers a balance between affordability and performance, making it an attractive choice for a wide range of medical applications such as tubing, intravenous (IV) bags, and blood transfusion sets. Furthermore, the excellent properties of PVC, including flexibility, durability, and chemical resistance, make it suitable for various medical devices and equipment, driving its adoption across healthcare settings. Additionally, stringent regulatory standards mandating the use of safe and sterile materials in medical applications further boost the demand for PVC, as it meets regulatory requirements effectively. Moreover, the versatility of PVC enables manufacturers to produce a wide range of medical products tailored to specific healthcare needs, catering to diverse patient populations and medical procedures. Apart from this, the COVID-19 pandemic has underscored the importance of PVC in healthcare, particularly in the production of essential medical supplies such as PPE kits and medical packaging, further driving its demand.
Breakup by Application:
Disposables
Drug Delivery Devices
Diagnostic Instruments
Catheters
Surgical Instruments
Others
Disposables represents the leading market segment
The disposables segment in medical plastics is driven by several key factors, each influencing its growth trajectory significantly, such as the increasing demand for single-use medical products in healthcare settings fuels the growth of the disposables segment. With the rising emphasis on infection prevention and control, healthcare facilities prioritize the use of disposable medical items to minimize the risk of cross-contamination and nosocomial infections. This heightened focus on patient safety drives the adoption of disposable medical plastics, including syringes, catheters, gloves, and surgical drapes, among others. Secondly, the expanding healthcare infrastructure, particularly in emerging economies, drives the demand for disposable medical plastics. As healthcare access improves and medical facilities expand, there is a growing need for affordable and easily accessible medical supplies, leading to increased consumption of disposable medical products made from plastics. Moreover, the disposables segment is propelled by advancements in manufacturing technologies, such as injection molding and extrusion, which enable cost-effective production of disposable medical plastics at scale.
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Asia Pacific leads the market, accounting for the largest medical plastics market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific represents the largest regional market for medical plastics.
The Asia Pacific region is driven by the increasing demand for medical devices and equipment, fueled by the region's growing population and rising healthcare needs. With expanding economies and improving healthcare infrastructure, countries in the Asia Pacific are witnessing a surge in demand for medical plastics to support their healthcare systems. Additionally, the prevalence of chronic diseases is on the rise in the region, driving the demand for medical interventions and therapies, thus increasing the need for medical plastics. Furthermore, stringent regulatory standards mandating the use of safe and sterile materials in healthcare settings are influencing the adoption of medical-grade plastics in the Asia Pacific region, ensuring compliance with international quality and safety standards.
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the medical plastics industry include Arkema SA, BASF SE, Celanese Corporation, Covestro AG, The Dow Chemical Company, DuPont de Nemours Inc, Evonik Industries AG, Exxon Mobil Corporation, SABIC, Solvay S.A., The Lubrizol Corporation (Berkshire Hathaway Inc.), Trinseo PLC, etc.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Key players in the medical plastics market are actively engaged in various strategies to maintain and enhance their market positions. These strategies include product innovation and development to meet evolving customer needs and regulatory requirements. Companies are investing significantly in research and development (R&D) activities to introduce novel materials and technologies that offer improved performance, biocompatibility, and cost-effectiveness. Moreover, strategic partnerships, collaborations, and mergers and acquisitions are prevalent among key players, facilitating access to new markets, technologies, and distribution channels. Additionally, market players are focusing on expanding their global presence through geographical expansion and market penetration strategies, targeting emerging economies with growing healthcare infrastructures. Furthermore, sustainability initiatives are gaining traction among key players, with a growing emphasis on developing eco-friendly and recyclable medical plastics to address environmental concerns and align with regulatory trends towards sustainability. Moreover, investments in manufacturing capabilities and supply chain optimization are being made to enhance operational efficiency and meet the increasing demand for medical plastics globally.
Key Questions Answered in This Report
1.What was the size of the global medical plastics market in 2024?
2.What is the expected growth rate of the global medical plastics market during 2025-2033?
3.What has been the impact of COVID-19 on the global medical plastics market?
4.What are the key factors driving the global medical plastics market?
5.What is the breakup of the global medical plastics market based on the material?
6.What is the breakup of the global medical plastics market based on the application?
7.What are the key regions in the global medical plastics market?
8.Who are the key players/companies in the global medical plastics market?
Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Medical Plastics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Material
6.1 Polyvinyl Chloride (PVC)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Polypropylene (PP)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Engineering Plastics
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Polyethylene (PE)
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Polystyrene (PS)
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Silicones
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast
7 Market Breakup by Application
7.1 Disposables
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Drug Delivery Devices
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Diagnostic Instruments
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Catheters
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Surgical Instruments
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Arkema SA
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 BASF SE
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Celanese Corporation
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Covestro AG
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.5 The Dow Chemical Company
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.6 DuPont de Nemours Inc
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 Evonik Industries AG
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 Exxon Mobil Corporation
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.9 SABIC
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Solvay S.A.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 The Lubrizol Corporation (Berkshire Hathaway Inc.)